Author

J. Karnes

Observed names: Jeffrey A. Karnes, Jeffrey Karnes

Observed institution: Mayo Clinic

OpenAlex ID: A5025625100

544 Long-term impact of adjuvant versus early salvage radiation therapy on clinical recurrence in pT3N0 prostate cancer patients treated with radical prostatectomy: Results of a multi-institutional analysis

2016 · N. Fossati, J. Karnes, et al. · European Urology Supplements · 6

Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model

2017 · D. Dalela, M. Santiago-Jimenez, et al. · European Urology Supplements · 4

Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients With Node Positive Prostate Cancer. a New Proposal Based on a Two Institution Experience on 784 Consecutive N+ Patients

2008 · A. Briganti, J. Karnes, et al. · European Urology Supplements · 4

Survival for patients with residual tumor at radical cystectomy following chemotherapy: A matched analysis to cystectomy-only patients.

2017 · Bimal Bhindi, Igor Frank, et al. · Journal of Clinical Oncology · 3

1001 The impact of re-TUR on clinical outcomes in a large cohort of t1g3 patients treated with BCG

2014 · P. Gontero, R. Sylvester, et al. · European Urology Supplements · 3

Defining biochemical response after salvage lymph node dissection in patients treated for nodal recurrence of prostate cancer: Results from a large multi-institutional series

2018 · N. Fossati, N. Suardi, et al. · European Urology Supplements · 2

Cytoreductive radical prostatectomy (cRP) is feasible in men with hormone-naive, metastatic prostate cancer (mPCA)

2017 · A. Heidenreich, A. Briganti, et al. · European Urology Supplements · 2

435 Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk

2016 · A. Ross, R. Den, et al. · European Urology Supplements · 2

Pd17-11 the Impact of Different Bcg Strains on Outcome in a Large Cohort of T1g3 Patients Treated With Bcg.

2015 · Paolo Gontero, Richard Sylvester, et al. · The Journal of Urology · 2

Multi-institutional external validation of the EAU guidelines recommendations for the use of staging mpMRI prior to radical prostatectomy in men with intermediate and high-risk prostate cancer

2018 · P. Diana, P. Dell’Oglio, et al. · European Urology Supplements · 1

Trend of use of adjuvant and salvage radiation therapy after radical prostatectomy and impact on long-term outcomes: Results from three high volume centers over the last two decades

2018 · F. Cianflone, A. Martini, et al. · European Urology Supplements · 1

Gleason score 6 prostate cancer is not always harmless

2018 · S. Joniau, M. Spyrantis, et al. · European Urology Supplements · 1

Oncological outcome of radical salvage prostatectomy in a large contemporary series

2018 · A. Heidenreich, M. Soligo, et al. · European Urology Supplements · 1

11C-choline versus 68Ga-PSMA PET/CT scan for the detection of nodal recurrence from prostate cancer: Results from a large, multi-institutional salvage lymph node dissection series

2017 · N. Fossati, A. Briganti, et al. · European Urology Supplements · 1

The effect of adjuvant chemotherapy for patients with adverse pathology after neoadjuvant chemotherapy for muscle invasive bladder cancer.

2017 · William P. Parker, Elizabeth B. Habermann, et al. · Journal of Clinical Oncology · 1

The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to preoperative staging. A comparison between 68Ga-PSMA-PET versus conventional imaging in a large, multi-institutional study

2022 · G. Sorce, G. Rosiello, et al. · European Urology

Mp15-07 Analysis of Perioperative Complications in Patients With Prostate Cancer Based on Extension of Pelvic Lymph Node Dissection

2021 · Marissa Maas, Nima Nassiri, et al. · The Journal of Urology

Pd53-10 Predicting Limited Survival for Patients With Penile Cancer Undergoing Inguinal Lymph Node Dissection

2021 · Lee Hugar, Nicholas Chakiryan, et al. · The Journal of Urology

Radiographic paradoxical response in patients with metastatic castrate-resistant prostate cancer (mCRPC) undergoing treatment with second-generation hormone therapy (second-HT).

2020 · Jamal Alamiri, Mohamed E. Ahmed, et al. · Journal of Clinical Oncology

Addition of carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in post-second generation hormone therapy setting: Does it improve treatment response and survival outcomes?

2020 · Jamal Alamiri, Mohamed E. Ahmed, et al. · Journal of Clinical Oncology

Mp37-17 Changing Patterns and Predictors of Salvage Radiation Therapy Use Over Time in Patients Treated for Post-prostatectomy Biochemical Recurrence: a Trend Analysis Over a 20-year Period From a Multi-institutional Series

2020 · Elio Mazzone*, Nicola Fossati, et al. · The Journal of Urology

PDF

Mp23-10 Are Men With Low Risk Prostate Cancer but High Pirads Score Lesions at Mpmri Still Candidate for Active Surveillance? Resuts From a Large, Multi-institutional Radical Prostatectomy Series

2020 · Armando Stabile*, Jeffrey Karnes, et al. · The Journal of Urology

Mp64-01 Patient Reported Quality of Life Measures 15 Years Post-radical Prostatectomy: a Matched Comparison of Open Retropubic and Robot Assisted Techniques

2020 · Tristan Juvet, Malek Meskawi, et al. · The Journal of Urology

Mp56-06 Should We Target All Visible Areas at Mpmri Suspicious for Clinically Significant Prostate Cancer in Addition to the Index Lesion? Results From a Two-institution Series

2020 · Armando Stabile*, Jeffrey Karnes, et al. · The Journal of Urology

Pd16-04 Radical Prostatectomy Versus Radiotherapy in M1a and Low Volume M1b Prostate Cancer Patients: an Indirect Comparison With the Stampede Trial Arm H

2020 · Giorgio Gandaglia*, Axel Heidenreich, et al. · The Journal of Urology

Works count: 81

Citation count: 34

H-index: 3

I10-index: